Akihiko Gotoh

18PUBLICATIONS
61CO-AUTHORS
Molecular targetsHaematological tumoursRespiratory diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 21, 2026
Therapeutic Potential of Exportin 1 and Aurora Kinase A Inhibition in Multiple Myeloma Cells.

Seiichi Okabe, Yuko Tanaka, Shunsuke Otsuki

|Jan 07, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners.

Kazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda

|Jul 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh

|Jun 14, 2025
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies.

Jens Panse, Bing Han, Jaroslav Cermak

|Feb 08, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.

Satoshi Iyama, SungGi Chi, Masashi Idogawa

|Feb 06, 2025
Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418.

Seiichi Okabe, Yuya Arai, Akihiko Gotoh

Pageof 3

Frequent Collaborators

6 joint publications

Seiichiro Katagiri

3 joint publications

Daigo Akahane

2 joint publications

Yasuhito Nannya

2 joint publications

Akifumi Takaori-Kondo